Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Asthma

  Free Subscription


Articles published in Clin Exp Allergy

Retrieve available abstracts of 70 articles:
HTML format



Single Articles


    September 2022
  1. NOWAK-JUREK A, Gajewski A, Frachowicz-Guereirro K, Antczak-Marczak M, et al
    Cytokines in serum, nasal secretion and exhaled breath condensate during mepolizumab therapy in patients with different phenotypes of severe eosinophilic asthma: A pilot study.
    Clin Exp Allergy. 2022 Sep 15. doi: 10.1111/cea.14231.
    PubMed    


  2. KERE M, Klevebro S, Hernandez-Pacheco N, Odling M, et al
    Exploring proteomic plasma biomarkers in eosinophilic and neutrophilic asthma.
    Clin Exp Allergy. 2022 Sep 14. doi: 10.1111/cea.14229.
    PubMed     Abstract available


  3. WHEATLEY LM, Holloway JW, Svanes C, Sears MR, et al
    The Role of Epigenetics in Multi-generational Transmission of Asthma: an NIAID Workshop Report-based narrative review.
    Clin Exp Allergy. 2022 Sep 8. doi: 10.1111/cea.14223.
    PubMed     Abstract available


  4. MANSUR AH, Gonem S, Brown T, Burhan H, et al
    Biologic therapy practices in severe asthma; outcomes from the UK Severe Asthma Registry and survey of specialist opinion.
    Clin Exp Allergy. 2022 Sep 3. doi: 10.1111/cea.14222.
    PubMed     Abstract available


  5. LOPEZ DJ, Lodge CJ, Bui DS, Waidyatillake NT, et al
    Establishing subclasses of childhood eczema, their risk factors and prognosis.
    Clin Exp Allergy. 2022;52:1079-1090.
    PubMed     Abstract available


    August 2022
  6. KIM JH, Ha EK, Lee SW, Cha HR, et al
    Growth pattern during early infancy, body mass index during childhood, and childhood asthma.
    Clin Exp Allergy. 2022 Aug 29. doi: 10.1111/cea.14221.
    PubMed     Abstract available


  7. VENEGAS C, Mukherjee M, Bhalla A, Nair P, et al
    Airway Autoimmunity, Asthma Exacerbations, and Response to Biologics.
    Clin Exp Allergy. 2022 Aug 22. doi: 10.1111/cea.14220.
    PubMed     Abstract available


  8. ERMIS SSO, Borres MP, Basna R, Ekerljung L, et al
    Sensitization to molecular dog allergens in an adult population: Results from the West Sweden Asthma Study.
    Clin Exp Allergy. 2022 Aug 19. doi: 10.1111/cea.14216.
    PubMed     Abstract available


    July 2022
  9. CHAKRABORTY S, Hammar KS, Filiou AE, Holmdahl I, et al
    Longitudinal Eosinophil-derived neurotoxin measurements and asthma development in preschool wheezers.
    Clin Exp Allergy. 2022 Jul 30. doi: 10.1111/cea.14210.
    PubMed    


  10. NICHOLAS B, Guo J, Lee HH, Bailey A, et al
    Analysis of cell-specific peripheral blood biomarkers in severe allergic asthma identifies innate immune dysfunction.
    Clin Exp Allergy. 2022 Jul 27. doi: 10.1111/cea.14197.
    PubMed    


  11. BREW BK, Caffrey Osvald E, Gong T, Hedman AM, et al
    Pediatric asthma and non-allergic comorbidities: a review of current risk and proposed mechanisms.
    Clin Exp Allergy. 2022 Jul 21. doi: 10.1111/cea.14207.
    PubMed     Abstract available


  12. BREW BK, Almqvist C, Lundholm C, Andreasson A, et al
    Comorbidity of atopic diseases and gastro-oesophageal reflux: evidence of a shared cause.
    Clin Exp Allergy. 2022;52:868-877.
    PubMed     Abstract available


  13. FENG M, Luo T, Xian M, Shi X, et al
    Suppression function against environmental dust exposure after Dermatophagoides pteronyssinus immunotherapy is associated with production of specific and cross-reactive immunoglobulin G4.
    Clin Exp Allergy. 2022;52:878-887.
    PubMed     Abstract available


    June 2022
  14. CHAN R, Lipworth BJ
    Oscillometry bronchodilator response in adult moderate to severe eosinophilic asthma patients: A prospective cohort study.
    Clin Exp Allergy. 2022 Jun 16. doi: 10.1111/cea.14185.
    PubMed    


    May 2022
  15. MUEHLING LM, Heymann PW, Carper H, Murphy DD, et al
    Cluster Analysis of Nasal Cytokines During Rhinovirus Infection Identifies Different Immunophenotypes in Both Children and Adults with Allergic Asthma.
    Clin Exp Allergy. 2022 May 16. doi: 10.1111/cea.14176.
    PubMed     Abstract available


  16. BOBROWSKA-KORZENIOWSKA M, Majak P, Brzozowska A, Polanska K, et al
    Cluster analysis of exhaled volatile organic compounds (VOCs) - link between environmental exposure and asthma in preschool children.
    Clin Exp Allergy. 2022 May 13. doi: 10.1111/cea.14175.
    PubMed    


  17. JONES CJ, Paudyal P, West RM, Mansur AH, et al
    Burden of allergic disease among ethnic minority groups in high-income countries.
    Clin Exp Allergy. 2022;52:604-615.
    PubMed     Abstract available


  18. MATUCCI A, Nencini F, Maggiore G, Chiccoli F, et al
    High proportion of inflammatory CD62L(low) eosinophils in blood and nasal polyps of severe asthma patients.
    Clin Exp Allergy. 2022 May 1. doi: 10.1111/cea.14153.
    PubMed     Abstract available


    April 2022
  19. MILLER M, Pham AK, Gonen A, Navia-Pelaez JM, et al
    Reduced AIBP expression in bronchial epithelial cells of asthmatic patients: Potential therapeutic target.
    Clin Exp Allergy. 2022 Apr 23. doi: 10.1111/cea.14150.
    PubMed    


  20. HARPER V, Trayer J
    Breathing exercises for adults with asthma.
    Clin Exp Allergy. 2022 Apr 6. doi: 10.1111/cea.14141.
    PubMed    


  21. SHAMJI MH, Boyle RJ
    Immune modulation and the role of innate immune cells in allergy and asthma.
    Clin Exp Allergy. 2022;52:474-475.
    PubMed    


    March 2022
  22. OZYIGIT LP, Aktas EC, Gelmez YM, Ozturk AB, et al
    Functionality of Natural Killer cells in Obese Asthma Phenotypes.
    Clin Exp Allergy. 2022 Mar 31. doi: 10.1111/cea.14136.
    PubMed     Abstract available


  23. CARDOSO-VIGUEROS C, von Blumenthal T, Ruckert B, Rinaldi A, et al
    Leukocyte redistribution as immunological biomarker of corticosteroid resistance in severe asthma.
    Clin Exp Allergy. 2022 Mar 19. doi: 10.1111/cea.14128.
    PubMed     Abstract available


  24. KRISHNA MT, Singh AB, Gaur SN, Mahesh PA, et al
    Research priorities and strategies to improve asthma and allergy care in India.
    Clin Exp Allergy. 2022;52:367-369.
    PubMed    


    February 2022
  25. CAMERON A, Dhariwal J, Upton N, Jimenez IR, et al
    Type I Conventional Dendritic Cells Relate to Disease Severity in Virus-Induced Asthma Exacerbations.
    Clin Exp Allergy. 2022 Feb 24. doi: 10.1111/cea.14116.
    PubMed     Abstract available


  26. CHARLES D, Shanley J, Temple SN, Rattu A, et al
    Real-World Efficacy of Treatment with Benralizumab, Dupilumab, Mepolizumab and Reslizumab for Severe Asthma: A Systematic Review and Meta-analysis.
    Clin Exp Allergy. 2022 Feb 16. doi: 10.1111/cea.14112.
    PubMed     Abstract available


  27. BARBER C, Azim A, Newell C, Kyyaly A, et al
    Validation and further insight into the International Severe Asthma Registry (ISAR) eosinophil gradient algorithm in the Wessex AsThma CoHort of difficult asthma (WATCH) using historical blood eosinophil counts and induced sputum.
    Clin Exp Allergy. 2022 Feb 13. doi: 10.1111/cea.14109.
    PubMed    


  28. MORGENSTERN-KAPLAN D, Gonzalez-Estrada A
    Is the use of a combined FABA/ICS single inhaler for mild asthma effective and safe?
    Clin Exp Allergy. 2022 Feb 3. doi: 10.1111/cea.14101.
    PubMed    


  29. KOTSAPAS C, Nicolaou N, Haider S, Kerry G, et al
    Early-life predictors and risk factors of peanut allergy, and its association with asthma in later-life: Population-based birth cohort study.
    Clin Exp Allergy. 2022 Feb 2. doi: 10.1111/cea.14103.
    PubMed     Abstract available


  30. SHAMJI MH, Boyle RJ
    Biomarker strategies for perioperative hypersensitivity reactions and severe eosinophilic asthma.
    Clin Exp Allergy. 2022;52:216-218.
    PubMed    


  31. YANG WH, Kelly S, Haya L, Mehri R, et al
    Cat allergen exposure in a naturalistic exposure chamber: A prospective observational study in cat-allergic subjects.
    Clin Exp Allergy. 2022;52:265-275.
    PubMed     Abstract available


  32. PATEL PP, Cui J, Cahill KN, Laidlaw TM, et al
    Objective validity of patient-reported symptoms in aspirin-exacerbated respiratory disease patients.
    Clin Exp Allergy. 2022;52:348-351.
    PubMed    


    January 2022
  33. LI L, Holloway JW, Ewart S, Arshad SH, et al
    Newborn DNA methylation and asthma acquisition across adolescence and early adulthood.
    Clin Exp Allergy. 2022 Jan 7. doi: 10.1111/cea.14091.
    PubMed     Abstract available


  34. WARNER JO, Warner JA, Munblit D
    Hypotheses to explain the associations between asthma and the consequences of COVID-19 infection.
    Clin Exp Allergy. 2022;52:7-9.
    PubMed    


  35. SIM S, Choi Y, Lee DH, Lee HR, et al
    Contribution of dipeptidyl peptidase 10 to airway dysfunction in patients with NSAID-exacerbated respiratory disease.
    Clin Exp Allergy. 2022;52:115-126.
    PubMed     Abstract available


    December 2021
  36. WANG J, Chai J, Zhang L, Zhang L, et al
    Microbiota Associations with Inflammatory Pathways in Asthma.
    Clin Exp Allergy. 2021 Dec 28. doi: 10.1111/cea.14089.
    PubMed     Abstract available


  37. MCALEES JW, Baker T, Houshel L, McKnight C, et al
    Increased Nasal Epithelial Cell Responsiveness to IL-17A in Pediatric Asthmatics with Low Blood Neutrophil Count, Low Traffic Related Air Pollution Exposure, and Good Asthma Control.
    Clin Exp Allergy. 2021 Dec 15. doi: 10.1111/cea.14080.
    PubMed    


  38. LARENAS-LINNEMANN D, Navarrete-Rodriguez EM, Luna-Pech JA, Benitez R, et al
    An independent in-depth analysis proposing adjusted Global Initiative on Asthma (GINA) Step 1-2 treatment suggestions.
    Clin Exp Allergy. 2021 Dec 13. doi: 10.1111/cea.14079.
    PubMed     Abstract available


  39. RISCASSI S, Corradi M, Andreoli R, Maccari C, et al
    Nitric oxide products and aldehydes in exhaled breath condensate in children with asthma.
    Clin Exp Allergy. 2021 Dec 10. doi: 10.1111/cea.14066.
    PubMed    


  40. KANG H, Bang JY, Mo Y, Shin JW, et al
    Effect of Acinetobacter lwoffii on the modulation of macrophage activation and asthmatic inflammation.
    Clin Exp Allergy. 2021 Dec 7. doi: 10.1111/cea.14077.
    PubMed     Abstract available


  41. GEREIGE JD, Morin A, Calatroni A, Visness CM, et al
    17q12-q21 variants interact with early-life exposures to modify asthma risk in Black children.
    Clin Exp Allergy. 2021 Dec 4. doi: 10.1111/cea.14074.
    PubMed     Abstract available


  42. HASSOUN D, Malard O, Barbarot S, Magnan A, et al
    Type 2 immunity-driven diseases: Towards a multidisciplinary approach.
    Clin Exp Allergy. 2021;51:1538-1552.
    PubMed     Abstract available


  43. SCALA E, Caprini E, Abeni D, Meneguzzi G, et al
    A qualitative and quantitative comparison of IgE antibody profiles with two multiplex platforms for component-resolved diagnostics in allergic patients.
    Clin Exp Allergy. 2021;51:1603-1612.
    PubMed     Abstract available


    November 2021
  44. MANISCALCO M
    Effectiveness of Benralizumab in severe eosinophilic asthma: distinct sub-phenotypes of response identified by cluster analysis by Di Bona et al.
    Clin Exp Allergy. 2021 Nov 18. doi: 10.1111/cea.14059.
    PubMed     Abstract available


  45. WARDZYNSKA A, Pawelczyk M, Rywaniak J, Makowska JS, et al
    MicroRNA expression profile in peripheral blood mononuclear cells of asthmatic patients and healthy individuals: The effect of age and ex vivo rhinovirus exposure.
    Clin Exp Allergy. 2021 Nov 12. doi: 10.1111/cea.14045.
    PubMed    


  46. FEO BRITO F, Arias TA, Amo-Salas M, Somoza Alvarez ML, et al
    Clinical impact and immunological alterations in asthmatic patients allergic to grass pollen subjected to high urban pollution in Madrid.
    Clin Exp Allergy. 2021 Nov 6. doi: 10.1111/cea.14041.
    PubMed     Abstract available


  47. PARRHASARATHI A, Padukudru S, Krishna MT, Mahesh PA, et al
    Clinical Characterisation of Asthma with Fungal Sensitisation in a South Indian Paediatric Cohort.
    Clin Exp Allergy. 2021 Nov 4. doi: 10.1111/cea.14038.
    PubMed     Abstract available


  48. VENTER C, Pickett K, Starling A, Maslin K, et al
    Advanced glycation end product intake during pregnancy and offspring allergy outcomes: A Prospective cohort study.
    Clin Exp Allergy. 2021;51:1459-1470.
    PubMed     Abstract available


    October 2021
  49. CAFFREY OSVALD E, Gong T, Lundholm C, Larsson H, et al
    Parental socioeconomic status and asthma in children - using a population-based cohort and family design.
    Clin Exp Allergy. 2021 Oct 22. doi: 10.1111/cea.14037.
    PubMed     Abstract available


  50. YAMAMOTO-HANADA K, Pak K, Sato M, Kram YE, et al
    Associations of frequent emollient use with wheeze and asthma in young Japanese children: A survey of well-child visits.
    Clin Exp Allergy. 2021 Oct 19. doi: 10.1111/cea.14035.
    PubMed     Abstract available


  51. DI BONA D, Crimi C, D'Uggento AM, Benfante A, et al
    Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub-phenotypes of response identified by cluster analysis.
    Clin Exp Allergy. 2021 Oct 4. doi: 10.1111/cea.14026.
    PubMed     Abstract available


  52. WAMBRE ER, Farrington M, Bajzik V, DeBerg HA, et al
    Clinical and Immunological Evaluation of Cat-allergic Asthmatics Living With or Without a Cat.
    Clin Exp Allergy. 2021 Oct 2. doi: 10.1111/cea.14024.
    PubMed     Abstract available


    September 2021
  53. MITCHELL RJ, McMaugh A, Homaira N, Lystad RP, et al
    The impact of childhood asthma on academic performance: a matched population-based cohort study.
    Clin Exp Allergy. 2021 Sep 26. doi: 10.1111/cea.14022.
    PubMed     Abstract available


    August 2021
  54. ISHII T, Murakami Y, Narita T, Nunokawa H, et al
    Myeloid differentiation protein-2 has a protective role in house dust mite-mediated asthmatic characteristics with the proinflammatory regulation of airway epithelial cells and dendritic cells.
    Clin Exp Allergy. 2021 Aug 21. doi: 10.1111/cea.14002.
    PubMed     Abstract available


  55. TYRAK KE, Pajdzik K, Jakiela B, Kuprys-Lipinska I, et al
    Biomarkers for predicting response to aspirin therapy in aspirin-exacerbated respiratory disease.
    Clin Exp Allergy. 2021;51:1046-1056.
    PubMed     Abstract available


    June 2021
  56. WRAITH DC, Krishna MT
    Peptide allergen-specific immunotherapy for allergic airway diseases-State of the art.
    Clin Exp Allergy. 2021;51:751-769.
    PubMed     Abstract available


  57. HACCURIA A, Van Muylem A, Malinovschi A, Rasschaert J, et al
    Increased expression of IL-33 is found in the lower airways of patients with seasonal allergic rhinitis and is not related to natural allergen exposure.
    Clin Exp Allergy. 2021;51:845-848.
    PubMed    


    May 2021
  58. IDROSE NS, Walters EH, Zhang J, Vicendese D, et al
    Outdoor pollen-related changes in lung function and markers of airway inflammation: A systematic review and meta-analysis.
    Clin Exp Allergy. 2021;51:636-653.
    PubMed     Abstract available


    April 2021
  59. SHAMJI MH, Boyle RJ
    New innovations in allergy treatment and phenotyping.
    Clin Exp Allergy. 2021;51:514-517.
    PubMed    


  60. ESNAULT S, Khosravi M, Kelly EA, Liu LY, et al
    Increased IL-6 and Potential IL-6 trans-signalling in the airways after an allergen challenge.
    Clin Exp Allergy. 2021;51:564-573.
    PubMed     Abstract available


    February 2021
  61. SHAMJI MH, Boyle RJ
    What does climate change mean for people with pollen allergy?
    Clin Exp Allergy. 2021;51:202-205.
    PubMed    


  62. AIROUCHE S, Beltrami V, Fleury S, Batard T, et al
    Bet v 1 contiguous overlapping peptides anchored to virosomes with TLR4 agonist enhance immunotherapy efficacy in mice.
    Clin Exp Allergy. 2021;51:339-349.
    PubMed     Abstract available


    January 2021
  63. KOEFOED HJL, Gehring U, Vonk JM, Koppelman GH, et al
    Blood eosinophils associate with reduced lung function growth in adolescent asthmatics.
    Clin Exp Allergy. 2021 Jan 1. doi: 10.1111/cea.13818.
    PubMed     Abstract available


  64. MPAIRWE H, Nkurunungi G, Tumwesige P, Akurut H, et al
    Risk factors associated with rhinitis, allergic conjunctivitis and eczema among schoolchildren in Uganda.
    Clin Exp Allergy. 2021;51:108-119.
    PubMed     Abstract available


  65. SUBRAMANIAN A, Adderley NJ, Gkoutos GV, Gokhale KM, et al
    Ethnicity-based differences in the incident risk of allergic diseases and autoimmune disorders: A UK-based retrospective cohort study of 4.4 million participants.
    Clin Exp Allergy. 2021;51:144-147.
    PubMed    


  66. SMITH BM, Zhao N, Olivenstein R, Lemiere C, et al
    Asthma and fixed airflow obstruction: Long-term trajectories suggest distinct endotypes.
    Clin Exp Allergy. 2021;51:39-48.
    PubMed     Abstract available


    November 2020
  67. FLORA M, Perna F, Abbadessa S, Garziano F, et al
    Basophil activation test for Staphylococcus aureus enterotoxins in severe asthmatic patients.
    Clin Exp Allergy. 2020 Nov 1. doi: 10.1111/cea.13772.
    PubMed     Abstract available


    October 2020
  68. MCCRAE C
    INEXAS: A Phase 2 Randomised Trial of On-Demand Inhaled Interferon Beta-1a in Severe Asthmatics.
    Clin Exp Allergy. 2020 Oct 22. doi: 10.1111/cea.13765.
    PubMed     Abstract available


  69. JABBAL S, Kuo CR, Lipworth B
    Randomized controlled trial of triple versus dual inhaler therapy on small airways in smoking asthmatics.
    Clin Exp Allergy. 2020;50:1140-1147.
    PubMed     Abstract available


    September 2020
  70. DU K, Zheng M, Zhao Y, Xu W, et al
    Impaired small airway function in non-asthmatic chronic rhinosinusitis with nasal polyps.
    Clin Exp Allergy. 2020 Sep 28. doi: 10.1111/cea.13747.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Asthma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: